Does the media prefer ILMN or TMO?

In the previous week, Thermo Fisher Scientific had 23 more articles in the media than Illumina. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 37 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Illumina's score of 0.94 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 17 Very Positive mention(s) 5 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 51 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MEDP or TMO?

In the previous week, Thermo Fisher Scientific had 21 more articles in the media than Medpace. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 39 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Medpace's score of 0.97 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 25 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 51 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor A or TMO?

In the previous week, Thermo Fisher Scientific had 42 more articles in the media than Agilent Technologies. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 18 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.23 beat Thermo Fisher Scientific's score of 1.22 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 14 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 51 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TMO or AMN?

In the previous week, Thermo Fisher Scientific had 52 more articles in the media than AMN Healthcare Services. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 8 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.22 beat AMN Healthcare Services' score of 1.01 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 51 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BIO or TMO?

In the previous week, Thermo Fisher Scientific had 55 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 5 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.29 beat Thermo Fisher Scientific's score of 1.22 indicating that Bio-Rad Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 51 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Thermo Fisher Scientific (TMO) Competitors

$576.77 +0.31 (+0.05%)

Closing price 07/30/2026 03:59 PM Eastern

Extended Trading

$576.30 -0.46 (-0.08%)

As of 06:17 AM Eastern

Compare

TMO vs. ILMN, MEDP, A, AMN, and BIO

Should you buy Thermo Fisher Scientific stock or one of its competitors? MarketBeat compares Thermo Fisher Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Thermo Fisher Scientific include Illumina (ILMN), Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), and Bio-Rad Laboratories (BIO). These companies are all part of the "medical" sector.

How does Thermo Fisher Scientific compare to Illumina?

Illumina (NASDAQ:ILMN) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Illumina currently has a consensus target price of $156.88, indicating a potential downside of 23.51%. Thermo Fisher Scientific has a consensus target price of $617.14, indicating a potential upside of 7.00%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	7 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.39
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79

89.4% of Illumina shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 2.9% of Illumina shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Illumina has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.39B	7.06	$850M	$5.50	37.29
Thermo Fisher Scientific	$44.56B	4.81	$6.70B	$18.59	31.03

In the previous week, Thermo Fisher Scientific had 23 more articles in the media than Illumina. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 37 mentions for Illumina. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Illumina's score of 0.94 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	17 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	51 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Illumina has a net margin of 19.42% compared to Thermo Fisher Scientific's net margin of 15.04%. Illumina's return on equity of 31.01% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	19.42%	31.01%	12.22%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Summary

Thermo Fisher Scientific beats Illumina on 9 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Medpace?

Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Thermo Fisher Scientific had 21 more articles in the media than Medpace. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 39 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Medpace's score of 0.97 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	25 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	51 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has a net margin of 17.67% compared to Thermo Fisher Scientific's net margin of 15.04%. Medpace's return on equity of 110.15% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.38	$451.12M	$17.06	33.90
Thermo Fisher Scientific	$44.56B	4.81	$6.70B	$18.59	31.03

Medpace has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Medpace currently has a consensus target price of $584.18, suggesting a potential upside of 1.02%. Thermo Fisher Scientific has a consensus target price of $617.14, suggesting a potential upside of 7.00%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.15
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79

Summary

Thermo Fisher Scientific beats Medpace on 10 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.7%. Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. Agilent Technologies pays out 20.5% of its earnings in the form of a dividend. Thermo Fisher Scientific pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has raised its dividend for 9 consecutive years and Thermo Fisher Scientific has raised its dividend for 8 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.2% of Agilent Technologies shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Agilent Technologies currently has a consensus price target of $159.35, suggesting a potential upside of 14.87%. Thermo Fisher Scientific has a consensus price target of $617.14, suggesting a potential upside of 7.00%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Agilent Technologies is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79

In the previous week, Thermo Fisher Scientific had 42 more articles in the media than Agilent Technologies. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 18 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.23 beat Thermo Fisher Scientific's score of 1.22 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	14 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	51 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has a net margin of 19.55% compared to Thermo Fisher Scientific's net margin of 15.04%. Agilent Technologies' return on equity of 24.33% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Thermo Fisher Scientific has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$7.23B	5.42	$1.30B	$4.98	27.86
Thermo Fisher Scientific	$44.56B	4.81	$6.70B	$18.59	31.03

Agilent Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Summary

Agilent Technologies beats Thermo Fisher Scientific on 11 of the 20 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Thermo Fisher Scientific (NYSE:TMO) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	4.81	$6.70B	$18.59	31.03
AMN Healthcare Services	$2.73B	0.50	-$95.70M	-$0.87	N/A

Thermo Fisher Scientific presently has a consensus target price of $617.14, suggesting a potential upside of 7.00%. AMN Healthcare Services has a consensus target price of $29.00, suggesting a potential downside of 16.79%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, equities research analysts plainly believe Thermo Fisher Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Thermo Fisher Scientific has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

In the previous week, Thermo Fisher Scientific had 52 more articles in the media than AMN Healthcare Services. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 8 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.22 beat AMN Healthcare Services' score of 1.01 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	51 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific has a net margin of 15.04% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Summary

Thermo Fisher Scientific beats AMN Healthcare Services on 14 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 30.3% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bio-Rad Laboratories currently has a consensus target price of $303.33, indicating a potential downside of 7.36%. Thermo Fisher Scientific has a consensus target price of $617.14, indicating a potential upside of 7.00%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.80
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	1 Strong Buy rating(s)	2.79

Bio-Rad Laboratories has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Bio-Rad Laboratories. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58B	3.39	$759.90M	$6.07	53.94
Thermo Fisher Scientific	$44.56B	4.81	$6.70B	$18.59	31.03

In the previous week, Thermo Fisher Scientific had 55 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 60 mentions for Thermo Fisher Scientific and 5 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.29 beat Thermo Fisher Scientific's score of 1.22 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	51 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific has a net margin of 15.04% compared to Bio-Rad Laboratories' net margin of 6.52%. Thermo Fisher Scientific's return on equity of 17.09% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	6.52%	3.56%	2.49%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Summary

Thermo Fisher Scientific beats Bio-Rad Laboratories on 13 of the 17 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMO vs. The Competition

Export

Metric	Thermo Fisher Scientific	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$214.22B	$7.68B	$7.04B	$23.53B
Dividend Yield	0.33%	1.27%	2.65%	4.19%
P/E Ratio	31.03	49.21	27.67	30.73
Price / Sales	4.81	96.69	491.02	81.94
Price / Cash	18.96	26.16	51.74	31.18
Price / Book	4.07	7.17	10.16	4.66
Net Income	$6.70B	$162.27M	$3.60B	$1.07B
7 Day Performance	1.66%	4.32%	0.66%	0.55%
1 Month Performance	15.27%	-1.02%	-3.29%	1.58%
1 Year Performance	23.36%	5.41%	24.48%	17.66%

Thermo Fisher Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMO Thermo Fisher Scientific	4.457 of 5 stars	$576.77 +0.1%	$617.14 +7.0%	+20.9%	$214.22B	$44.56B	31.03	125,000	Positive News Insider Trade Analyst Revision
ILMN Illumina	2.1026 of 5 stars	$184.68 -1.1%	$156.88 -15.1%	+92.3%	$27.94B	$4.34B	33.58	8,650	Trending News Earnings Report
MEDP Medpace	2.4482 of 5 stars	$527.93 -1.8%	$469.50 -11.1%	+32.1%	$15.08B	$2.53B	33.18	6,200	Insider Trade
A Agilent Technologies	4.7021 of 5 stars	$130.55 -0.7%	$159.35 +22.1%	+17.4%	$36.87B	$6.95B	26.21	18,100	Positive News
AMN AMN Healthcare Services	1.9853 of 5 stars	$33.72 -3.7%	$27.00 -19.9%	+87.5%	$1.31B	$2.73B	N/A	2,664	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TMO) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Do analysts rate ILMN or TMO?

Do institutionals & insiders believe in ILMN or TMO?

Which has more risk & volatility, ILMN or TMO?

Which has stronger earnings and valuation, ILMN or TMO?

Does the media prefer ILMN or TMO?

Is ILMN or TMO more profitable?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Do institutionals and insiders hold more shares of MEDP or TMO?

Does the media favor MEDP or TMO?

Is MEDP or TMO more profitable?

Which has preferable earnings & valuation, MEDP or TMO?

Which has more risk & volatility, MEDP or TMO?

Do analysts recommend MEDP or TMO?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Is A or TMO a better dividend stock?

Do institutionals & insiders believe in A or TMO?

Do analysts prefer A or TMO?

Does the media favor A or TMO?

Is A or TMO more profitable?

Which has better earnings and valuation, A or TMO?

Which has more risk and volatility, A or TMO?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Do institutionals and insiders have more ownership in TMO or AMN?

Which has higher valuation & earnings, TMO or AMN?

Do analysts prefer TMO or AMN?

Which has more risk & volatility, TMO or AMN?

Does the media favor TMO or AMN?

Is TMO or AMN more profitable?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Do insiders and institutionals believe in BIO or TMO?

Do analysts rate BIO or TMO?

Which has more volatility and risk, BIO or TMO?

Which has higher valuation and earnings, BIO or TMO?

Does the media favor BIO or TMO?

Is BIO or TMO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools